Efficacy of brodalumab in psoriasis patients with a body weight >100 kg: Real‐world evidence (RWE) from the LIBERO study

Efficacy of brodalumab in psoriasis patients with a body weight >100 kg: Real‐world evidence (RWE) from the LIBERO study

Abstract Background Patients with psoriasis often suffer from obesity. However, only limited data are available on the efficacy of brodalumab 210 mg, a fully human monoclonal immunoglobulin IgG2 antibody binding to the human interleukin 17 receptor subunit A, in obese patients in daily practice, to...

Full description

Saved in:
Bibliographic Details
Main Authors: Ralph vonKiedrowski, Khusru Asadullah, Bernhard Korge, Konstantina Tsarovina, Matthias Augustin
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:JEADV Clinical Practice
Subjects:
daily practice
IL‐17RA antagonist
non‐interventional study
obesity
Online Access:https://doi.org/10.1002/jvc2.556
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items